Introduction – Company Background

GuangXin Industrial Co., Ltd. is a specialized manufacturer dedicated to the development and production of high-quality insoles.

With a strong foundation in material science and footwear ergonomics, we serve as a trusted partner for global brands seeking reliable insole solutions that combine comfort, functionality, and design.

With years of experience in insole production and OEM/ODM services, GuangXin has successfully supported a wide range of clients across various industries—including sportswear, health & wellness, orthopedic care, and daily footwear.

From initial prototyping to mass production, we provide comprehensive support tailored to each client’s market and application needs.

At GuangXin, we are committed to quality, innovation, and sustainable development. Every insole we produce reflects our dedication to precision craftsmanship, forward-thinking design, and ESG-driven practices.

By integrating eco-friendly materials, clean production processes, and responsible sourcing, we help our partners meet both market demand and environmental goals.

Core Strengths in Insole Manufacturing

At GuangXin Industrial, our core strength lies in our deep expertise and versatility in insole and pillow manufacturing. We specialize in working with a wide range of materials, including PU (polyurethane), natural latex, and advanced graphene composites, to develop insoles and pillows that meet diverse performance, comfort, and health-support needs.

Whether it's cushioning, support, breathability, or antibacterial function, we tailor material selection to the exact requirements of each project-whether for foot wellness or ergonomic sleep products.

We provide end-to-end manufacturing capabilities under one roof—covering every stage from material sourcing and foaming, to precision molding, lamination, cutting, sewing, and strict quality control. This full-process control not only ensures product consistency and durability, but also allows for faster lead times and better customization flexibility.

With our flexible production capacity, we accommodate both small batch custom orders and high-volume mass production with equal efficiency. Whether you're a startup launching your first insole or pillow line, or a global brand scaling up to meet market demand, GuangXin is equipped to deliver reliable OEM/ODM solutions that grow with your business.

Customization & OEM/ODM Flexibility

GuangXin offers exceptional flexibility in customization and OEM/ODM services, empowering our partners to create insole products that truly align with their brand identity and target market. We develop insoles tailored to specific foot shapes, end-user needs, and regional market preferences, ensuring optimal fit and functionality.

Our team supports comprehensive branding solutions, including logo printing, custom packaging, and product integration support for marketing campaigns. Whether you're launching a new product line or upgrading an existing one, we help your vision come to life with attention to detail and consistent brand presentation.

With fast prototyping services and efficient lead times, GuangXin helps reduce your time-to-market and respond quickly to evolving trends or seasonal demands. From concept to final production, we offer agile support that keeps you ahead of the competition.

Quality Assurance & Certifications

Quality is at the heart of everything we do. GuangXin implements a rigorous quality control system at every stage of production—ensuring that each insole meets the highest standards of consistency, comfort, and durability.

We provide a variety of in-house and third-party testing options, including antibacterial performance, odor control, durability testing, and eco-safety verification, to meet the specific needs of our clients and markets.

Our products are fully compliant with international safety and environmental standards, such as REACH, RoHS, and other applicable export regulations. This ensures seamless entry into global markets while supporting your ESG and product safety commitments.

ESG-Oriented Sustainable Production

At GuangXin Industrial, we are committed to integrating ESG (Environmental, Social, and Governance) values into every step of our manufacturing process. We actively pursue eco-conscious practices by utilizing eco-friendly materials and adopting low-carbon production methods to reduce environmental impact.

To support circular economy goals, we offer recycled and upcycled material options, including innovative applications such as recycled glass and repurposed LCD panel glass. These materials are processed using advanced techniques to retain performance while reducing waste—contributing to a more sustainable supply chain.

We also work closely with our partners to support their ESG compliance and sustainability reporting needs, providing documentation, traceability, and material data upon request. Whether you're aiming to meet corporate sustainability targets or align with global green regulations, GuangXin is your trusted manufacturing ally in building a better, greener future.

Let’s Build Your Next Insole Success Together

Looking for a reliable insole manufacturing partner that understands customization, quality, and flexibility? GuangXin Industrial Co., Ltd. specializes in high-performance insole production, offering tailored solutions for brands across the globe. Whether you're launching a new insole collection or expanding your existing product line, we provide OEM/ODM services built around your unique design and performance goals.

From small-batch custom orders to full-scale mass production, our flexible insole manufacturing capabilities adapt to your business needs. With expertise in PU, latex, and graphene insole materials, we turn ideas into functional, comfortable, and market-ready insoles that deliver value.

Contact us today to discuss your next insole project. Let GuangXin help you create custom insoles that stand out, perform better, and reflect your brand’s commitment to comfort, quality, and sustainability.

🔗 Learn more or get in touch:
🌐 Website: https://www.deryou-tw.com/
📧 Email: shela.a9119@msa.hinet.net
📘 Facebook: facebook.com/deryou.tw
📷 Instagram: instagram.com/deryou.tw

ODM service for ergonomic pillows Taiwan

Are you looking for a trusted and experienced manufacturing partner that can bring your comfort-focused product ideas to life? GuangXin Industrial Co., Ltd. is your ideal OEM/ODM supplier, specializing in insole production, pillow manufacturing, and advanced graphene product design.

With decades of experience in insole OEM/ODM, we provide full-service manufacturing—from PU and latex to cutting-edge graphene-infused insoles—customized to meet your performance, support, and breathability requirements. Our production process is vertically integrated, covering everything from material sourcing and foaming to molding, cutting, and strict quality control.Flexible manufacturing OEM & ODM Indonesia

Beyond insoles, GuangXin also offers pillow OEM/ODM services with a focus on ergonomic comfort and functional innovation. Whether you need memory foam, latex, or smart material integration for neck and sleep support, we deliver tailor-made solutions that reflect your brand’s values.

We are especially proud to lead the way in ESG-driven insole development. Through the use of recycled materials—such as repurposed LCD glass—and low-carbon production processes, we help our partners meet sustainability goals without compromising product quality. Our ESG insole solutions are designed not only for comfort but also for compliance with global environmental standards.Smart pillow ODM manufacturer Taiwan

At GuangXin, we don’t just manufacture products—we create long-term value for your brand. Whether you're developing your first product line or scaling up globally, our flexible production capabilities and collaborative approach will help you go further, faster.Customized sports insole ODM factory Taiwan

📩 Contact us today to learn how our insole OEM, pillow ODM, and graphene product design services can elevate your product offering—while aligning with the sustainability expectations of modern consumers.Customized sports insole ODM Taiwan

A team of experts unanimously refuted the concept of a fetal microbiome and concluded that the detection of microbiomes in fetal tissues was due to the contamination of samples taken from the uterus. This contamination could have occurred during vaginal birth, medical procedures, or during laboratory testing. Leading experts from several scientific disciplines find flaws in studies that suggest the existence of a “fetal microbiome.” Scientific claims that babies harbor live bacteria while still in the womb are inaccurate, and may have impeded research progress, according to University College Cork (UCC) researchers at APC Microbiome Ireland, a world-leading Science Foundation Ireland (SFI) Research Centre, which led a perspective published today (January 25, 2023) in the prestigious scientific journal Nature.   Prior claims that the human placenta and amniotic fluid are normally colonized by bacteria would, if true, have serious implications for clinical medicine and pediatrics. It would also undermine established principles in immunology and reproductive biology. To examine these claims, UCC & APC Principal Investigator Prof. Jens Walter assembled a trans-disciplinary team of 46 leading experts in reproductive biology, microbiome science, and immunology from around the world to evaluate the evidence for microbes in human fetuses. University College Cork & APC Microbiome Ireland Principal Investigator Prof. Jens Walter assembled a trans-disciplinary team of 46 leading experts from around the world to evaluate the evidence for microbes in human fetuses. Credit: UCC A Healthy Human Fetus Is Sterile The team unanimously refuted the concept of a fetal microbiome and concluded that the detection of microbiomes in fetal tissues was due to contamination of samples drawn from the womb. Contamination occurred during vaginal delivery, clinical procedures, or during laboratory analysis. In the report in Nature, the international experts encourage researchers to focus their studies on the microbiomes of mothers and their newborn infants and on the microbial metabolites crossing the placenta which prepare the fetus for post-natal life in a microbial world. According to Prof. Walter: “This consensus provides guidance for the field to move forward, to concentrate research efforts where they will be most effective. Knowing that the fetus is in a sterile environment, confirms that colonization by bacteria happens during birth and in early post-natal life, which is where therapeutic research on modulation of the microbiome should be focused.” The expert international authors also provide guidance on how scientists in the future can avoid pitfalls of contamination in the analysis of other samples where microbes are expected to be absent or present at low levels, such as internal organs and tissues within the human body.   Reference: “Questioning the fetal microbiome and pitfalls of low-biomass microbial studies” by Katherine M. Kennedy, Marcus C. de Goffau, Maria Elisa Perez-Muñoz, Marie-Claire Arrieta, Fredrik Bäckhed, Peer Bork, Thorsten Braun, Frederic D. Bushman, Joel Dore, Willem M. de Vos, Ashlee M. Earl, Jonathan A. Eisen, Michal A. Elovitz, Stephanie C. Ganal-Vonarburg, Michael G. Gänzle, Wendy S. Garrett, Lindsay J. Hall, Mathias W. Hornef, Curtis Huttenhower, Liza Konnikova, Sarah Lebeer, Andrew J. Macpherson, Ruth C. Massey, Alice Carolyn McHardy, Omry Koren, Trevor D. Lawley, Ruth E. Ley, Liam O’Mahony, Paul W. O’Toole, Eric G. Pamer, Julian Parkhill, Jeroen Raes, Thomas Rattei, Anne Salonen, Eran Segal, Nicola Segata, Fergus Shanahan, Deborah M. Sloboda, Gordon C. S. Smith, Harry Sokol, Tim D. Spector, Michael G. Surette, Gerald W. Tannock, Alan W. Walker, Moran Yassour and Jens Walter, 25 January 2023, Nature. DOI: 10.1038/s41586-022-05546-8

Whole genome duplication (WGD) occurs across all life forms, notably in plants and aggressive cancers, leading to polyploidy where cells contain multiple genomes. This condition is linked to robustness and environmental adaptation but also presents challenges in DNA management, as evidenced in a new study examining how polyploid plant species evolved and managed their extra DNA, revealing diverse evolutionary strategies. New research explores the adaptation strategies of polyploid plants, offering insights for cancer treatment and enhancing crop resilience against environmental challenges. Whole genome duplication (WGD) occurs across all kingdoms of life. While it is most prevalent in plants, it also takes place in certain highly aggressive cancers. Following WGD, a cell acquires additional sets of genomes and is referred to as polyploid. Most of our major crops are also polyploid, including, wheat, apples, bananas, oats, strawberries, sugar, and brassicas like broccoli and cauliflower. Polyploidy also occurs in some of the most aggressive gliomas (a brain cancer) and is associated with cancer progression. In general, polyploidy has been associated with robustness (as in crops) and adaptation to the environment (as in cancers that metastasize). Because polyploids have more genomes to manage, the doubling of these genomes can be a weakness, so it is important to understand what factors stabilize young polyploids and how genome-doubled populations evolve. In this new study, published in Cell Reports, experts from the University of Nottingham’s School of Life Sciences look at how three successfully polyploid plant species evolved to manage the extra DNA and whether they each did this differently or all the same way. Research Insights from Polyploids Professor Levi Yant, who led the study said: “Understanding the range of issues that face polyploids may help us to understand why some succeed while others don’t. We see that successful polyploids overcome specific issues with DNA management and we focus on exactly what their ‘natural solutions’ are. “In our study, we looked at three instances where species have adapted to ‘polyploid life’ and not only survived, but even thrived. Then we looked at whether they used the same molecular solutions to survive. Surprisingly, they did not.” The researchers found that the clearest signal of rapid adaptation to the polyploid state came from the CENP-E molecule, which is an exact molecule that other groups recently found to be an Achilles heel for polypoid cancers, and is a promising therapeutic target to kill the cancers. The next clearest signal came from ‘meiosis genes’, which Professor Yant notes are turned on in many cancers, whereas they are turned off in nearly all normal cells. Implications for Cancer Research and Agriculture “We discovered signals of rapid adaptation to the WGD state in the same molecular networks, and in the case of CENP-E, the exact molecule that is specifically important to polyploid cancers,” continues Professor Yant. “This WGD gives cancer a short-term advantage over most therapies, but targeting that exact molecule, CENP-E, specifically kills the polyploid cancer. This is a striking example of evolutionary repetition (or convergence) from completely different directions, but to the same adaptive hurdle. We can now take this model that adapts well to polyploidy and that can inform our thinking about certain types of cancer.” The findings of the study could impact in better understanding of how certain polyploid cancers, such as gliomas (brain cancers) are able to use polyploidy to progress, and what molecules can be targeted as part of any therapy to ‘kill’ the cancer cells. More broadly, the study is important evidence that shows that mining evolutionary biology for these natural solutions can inform future therapies. Finally, the study also illustrates different ways in the future that we can better engineer our many polyploid crops to be more resilient to certain cataclysmic events – such as climate change. Reference: “Kinetochore and ionomic adaptation to whole-genome duplication in Cochlearia shows evolutionary convergence in three autopolyploids” by Sian M. Bray, Tuomas Hämälä, Min Zhou, Silvia Busoms, Sina Fischer, Stuart D. Desjardins, Terezie Mandáková, Chris Moore, Thomas C. Mathers, Laura Cowan, Patrick Monnahan, Jordan Koch, Eva M. Wolf, Martin A. Lysak, Filip Kolar, James D. Higgins, Marcus A. Koch and Levi Yant, 7 August 2024, Cell Reports. DOI: 10.1016/j.celrep.2024.114576 The study was funded by the European Research Council, BBSRC, and the Leverhulme Trust.

Researchers found an unexpected genetic variation in a new protist species, challenging established understanding of DNA-to-protein translation and emphasizing the mysteries that nature still holds. Scientists testing a new method of sequencing single cells have unexpectedly changed our understanding of the rules of genetics.  The genome of a protist has revealed a seemingly unique divergence in the DNA code signaling the end of a gene, suggesting the need for further research to better understand this group of diverse organisms. Dr. Jamie McGowan, a postdoctoral scientist at the Earlham Institute, analyzed the genome sequence of a microscopic organism – a protist – isolated from a freshwater pond at Oxford University Parks. The work was intended to test a DNA sequencing pipeline to work with very small amounts of DNA, such as DNA from a single cell. Dr. McGowan was working with a team of scientists at the Earlham Institute and with Professor Thomas Richards’ group at the University of Oxford. Unexpected Genetic Findings in Protists However, when researchers looked at the genetic code, the protist Oligohymenophorea sp. PL0344 turned out to be a novel species with an unlikely change in how its DNA is translated into proteins. Dr. McGowan said: “It’s sheer luck we chose this protist to test our sequencing pipeline, and it just shows what’s out there, highlighting just how little we know about the genetics of protists.” It is hard to make any statements about protists as a group. Most are microscopic, single-celled organisms like amoebas, algae, and diatoms, but larger multicellular protists exist – such as kelp, slime molds, and red algae.  “The definition of a protist is loose – essentially it is any eukaryotic organism which is not an animal, plant, or fungus,” said Dr. McGowan. “This is obviously very general, and that’s because protists are an extremely variable group. “Some are more closely related to animals, some more closely related to plants. There are hunters and prey, parasites and hosts, swimmers, and sitters, and there are those with varied diets while others photosynthesize. Basically, we can make very few generalizations.” Ciliates and Genetic Code Variations Oligohymenophorea sp. PL0344 is a ciliate. These swimming protists can be seen with a microscope and are found almost anywhere there is water.  Ciliates are hotspots for genetic code changes, including reassignment of one or more stop codons – the codons TAA, TAG, and TGA. In virtually all organisms, these three stop codons are used to signal the end of a gene. Variations in the genetic code are extremely rare. Among the few variants of the genetic code reported to date, the codons TAA and TAG virtually always have the same translation, suggesting that their evolution is coupled.  “In almost every other case we know of, TAA and TAG change in tandem,” explained Dr. McGowan. “When they aren’t stop codons, they each specify the same amino acid.”  DNA Translation Anomalies DNA is like a blueprint of a building. It does not do anything in and of itself – it provides instructions for work to be done. In order for a gene to have an impact, the blueprint must be “read” and then built into a molecule which has a physical effect.  For DNA to be read, it is first transcribed into an RNA copy. This copy is taken to another area of the cell where it is translated into amino acids, which are combined to make a three-dimensional molecule. The translation process starts at the DNA start codon (ATG) and finishes at a stop codon (normally TAA, TAG, or TGA).  In Oligohymenophorea sp. PL0344, only TGA functions as a stop codon – although Dr. McGowan found there are more TGA codons than expected in the ciliate’s DNA, believed to compensate for the loss of the other two. Instead, TAA specifies lysine and TAG specifies glutamic acid.   “This is extremely unusual,” Dr. McGowan said. “We’re not aware of any other case where these stop codons are linked to two different amino acids. It breaks some of the rules we thought we knew about gene translation – these two codons were thought to be coupled.  “Scientists attempt to engineer new genetic codes – but they are also out there in nature. There are fascinating things we can find, if we look for them.  “Or, in this case, when we are not looking for them.” Reference: “Identification of a non-canonical ciliate nuclear genetic code where UAA and UAG code for different amino acids” by Jamie McGowan, Estelle S. Kilias, Elisabet Alacid, James Lipscombe, Benjamin H. Jenkins, Karim Gharbi, Gemy G. Kaithakottil, Iain C. Macaulay, Seanna McTaggart, Sally D. Warring, Thomas A. Richards, Neil Hall and David Swarbreck, 5 October 2023, PLOS Genetics. DOI: 10.1371/journal.pgen.1010913 This research was funded by the Wellcome Trust as part of the Darwin Tree of Life Project, and supported by the Earlham Institute’s core funding from the Biotechnology and Biological Sciences Research Council (BBSRC), part of UKRI.

DVDV1551RTWW78V